Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 13, 2004 - Issue 6
Submit an article Journal homepage
380
Views
39
CrossRef citations to date
0
Altmetric
Review

Cataract formation and prevention

Hitoshi Shichi Kresge Eye Institute, Department of Ophthalmology, Wayne State University School of Medicine, 4717 St. Antoine, Detroit, MI 48201, USA. [email protected]
Pages 691-701 | Published online: 24 Feb 2005

Bibliography

  • THYLEFORS B, NEGREL AD, PARARAJASEGARAM R, DADZIE KY: Global data on blindness. Bull. World Health Organ. (1995) 73:115–121.
  • JAVITT JC: Who does cataract surgery in the United States? Arch. Ophthalmol. (1993) 111:1329.
  • JOSHI N, CONSTABLE PH, MARGOLIS TP, HOYL CS, LEONARD TJ: Bilateral angle closure glaucoma and accelerated cataract in a patient with AIDS. Br: J. Ophthalmol. (1994) 78:656–657.
  • SCHNAUDIGEL OE, GUMBEL H, RICHTER R, SUBKLEW R, GARWEGT: Ophthalmologic manifestations in early and late stages of AIDS. Ophthalmologe (1994) 91:668–670.
  • JAANUS SD: Drug-related cataract. Optom. Clin. (1991) 1:143–157.
  • HODGE W, WHITCHER JP, SATARIANO W: Risk factors for age-related cataracts. Epidemiol. Rev (1995) 17:336–346.
  • BROWN NA, BRON AJ, HARDING JJ, DEWAR HM: Nutrition supplements and the eye. Eye (1998) 12:127–133.
  • HARDING JJ: Can drugs or micronutrients prevent cataract? Drugs Aging (2001) 18:473–486.
  • CONGDON NG: Prevention strategies for age related cataract: Present limitations and future possibilities. Br. J. Ophthalmol. (2001)85(5):516–520.
  • ZIGMAN S, PAXHIA T, McDANIEL T, LOU MF, YU NT: Effect of chronic near-ultraviolet radiation on the gray squirrel lens M vivo. Invest. Ophthalmol. Vis. Sci (1991) 32:1723–1732.
  • HIGHTOWER KR: A review of the evidence that ultraviolet radiation is a risk factor in cataractogenesis. Doc. Ophthalmol. (1995) 88:205–220.
  • BALASUBRAMANIAN D: Ultraviolet radiation and cataract. J. Ocular Pharmacol. Therapeut. (2000) 16:285–297.
  • ROBERTS J, FINLEY EL, PATAT SA, SCHEY KL: Photowddation of lens proteins with xanthurenic acid: a putative chromophore for cataractogenesis. Photochem. Photobiol. (2001) 74:740–744.
  • WEINREB 0, DOVRAT A, DUNIA I, BENEDETTI EL, BLOEMENDAL H: UV-A-related alterations of young and adult lens water-insoluble a-crystallin, plasma membranous and cytoskeletal proteins. Ear: Biochem. (2001) 268:536–543.
  • DE JONG WW, LEUNISSEN JAM, VOORTER CEM: Evolution of the a-crystallin/small heat-shock protein family. Biol. Eva (1993) 10:103–126.
  • HORWITZ J: a-Crystallin can function as a molecular chaperone. Proc. Nati Acad. Sci.USA (1992) 89:10449–10453.
  • SLINEY DH: Physical factors in cataractogenesis: Ambient ultraviolet radiation and temperature. Invest. Ophthalmol. Vis. Sci. (1986) 27:781–790.
  • AYALA MN, MICHAEL R, SODERBERG PG: In vivo cataract after repeated exposure to ultraviolet radiation. Exp. Eye Res. (2000) 70:451–456.
  • TAYLOR HR, WEST SK, ROSENTHAL FS et al.: Effect of ultraviolet radiation on cataract formation. N Engl. J. Med. (1988) 320:1285–1286.
  • WEST SK, DUNCAN DD, MUNOZ B et al.: Sunlight exposure and risk of lens opacities in a population-based study. JAMA (1998) 280:714–718.
  • McCARTY CA, NANJAN MB, TAYLOR HR: Attributable risk estimates for cataract to prioritize medical and public health action. Invest. Ophthalmol. Vis. Sci. (2000) 41:3720–3725.
  • BOCHOW TW, WEST SK, AZAR A, MUNOZ B, SOMMER A, TAYLOR HR: Ultraviolet light exposure and risk of posterior subcapsular cataracts. Arch. Ophthalmol. (1989) 107:369–372.
  • FRANCIS P, CHUNG JJ, YASUI M et al.: Functional impairment of lens aquaporin in two families with dominantly inherited cataracts. Human Mol. Genet. (2000) 9:2329–2334.
  • NAKANO K, YAMAMOTO S, KATSUKAKE G, OGAWA H, NAKAJIMA A, TAKANO E: Hereditary cataract in mice. Jpn. I Clin. Ophthalmol. (1960) 14:196.
  • IWATA S, KINOSHITA JH: Mechanism of development of hereditary cataract in mice. Invest. Ophthalmo1.10:504–512.
  • KUWABARA T, KINOSHITA JH, COGAN DG: Electron microscopic study of galactose-induced cataract. Invest. Ophthalmol. (1969) 8:133–149.
  • ROBISON WG, HOULDER N, KINOSHITA JH: The role of lens epithelium in sugar cataract formation. Exp. Eye Res. (1990) 50:641–646.
  • KINOSHITA J: A thirty year journey in the polyol pathway. Exp. Eye Res. (1990) 50:567–573.
  • VAN HEYNINGEN R: Sorbitol pathway-reminiscences. Exp. Eye Res. (1990) 50:583–588.
  • CARPER D, NISHIMURA C, SHINOHARA T et al.: Aldose reductase and rho-crystallin belong to the same protein superfamily as aldehyde reductase. FEBS Lett. (1987) 220:209–213.
  • LUDVIGSON MA, SORENSON RL: Immunohistochemical localization of aldose reductase. II. Rat eye and kidney. Diabetes (1980) 29:450–459.
  • NISHIMURA C, AKAGI Y, ROBISON WG, KADOR PF, KINOSHITA JH: Increased aldose reductase activity in galactosemic lens. In: Polyol Pathway and Role M Diabetic Complications. N Sakamoto, JH Kinoshita, PF Kador, N Hotta (Eds), Elsevier, New York (1988):182–188.
  • STITT AW: Advanced glycation: an important pathological event in diabetic and age related ocular disease. Br. J. Ophthalmol. (2001) 85:746–753.
  • KONERU PB, LIEN EJ, KODA RT: Oculotoxicities of systemically administered drugs. J. Ocular Pharmacol. (1986) 2:385–404.
  • HOLLWICH F, BOATENG A, KOLCK B:Toxic cataract. In: Cataract and Abnormalities of the Lens. JG Bellows (Ed.), 13(6) Grune & Stratton, New York (1975):230–243.
  • CHENG Q, ROBISON WG, ZIGLER JS: Geranylgeranyl pyrophosphate counteracts the cataractogenic effect of lovastatin on cultured rat lenses. Exp. Eye Res. (2002) 75:603–609.
  • CENEDELLA RJ, KUSZAK JR, AL-GHOUL KJ, QIN S, SEXTON PS: Discordant expression of the sterol pathway in lens underlies simvastatin-induced cataracts in Chbb: thom rats. J. Lipid Res. (2003) 44:198–211.
  • SHICHI H: Biotransformation and drug metabolism. In: Pharmacology of the Eye. ML Sears (Ed.), Springer-Verlag, Berlin (1984):117–148.
  • O'BRIEN PJ: Molecular mechanisms of quinone cytotoxicity. Chem. Biol. Interact. (1991) 80:1–41.
  • SHICHI H, TANAKA M, JENSEN NM, NEBERT DW: Genetic differences in cataract and other ocular abnormalities induced by paracetamol and naphthalene. Pharmacology(1980) 20:229–241.
  • WELLS P, WILSON B, LUBEK BM: In vivo murine studies on the biochemical mechanism of naphthalene cataractogenesis. Toxicol Appl. Pharmacol (1989) 99:466–473.
  • XU GT, ZIGLER JS, LOU MF: The possible mechanism of naphthalene cataract in rat and its prevention by an aldolase reductase inhibitor (ALT 1576). Exp. Eye Res. (1992) 54:63–72.
  • BOLTON JL, TRUSH MA, PENNING TM, DRYHURST G, MONKS TJ: Role of quinones in toxicity. Chem. Res Toxicol (2000) 13:135–160.
  • SUGIYAMA K, WANG TL, SIMPSON JT, RODRIGUEZ L, KADOR P, SATO S: Aldose reductase catalyzes the oxidation of naphthalene-1, 2-dihydrodiol for the formation of ortho-naphthoquinone. Drug Met. Dispos. (1999) 27:60–67.
  • RAO PV, ZIGLER JS: Zeta-crystallin from guinea-pig lens is capable of functioning catalytically as an oxidoreductase. Arch. Biochem. Biophys. (1991) 284:181–185.
  • BAZZI MD: Interaction of camel lens zeta-crystallin with quinones: Portrait of a substrate by fluorescence spectroscopy. Arch. Biochem. Biophys. (2001) 395:185–190.
  • SHICHI H, GAASTERLAND DE, NEBERT DW: The Ah locus: genetic differences in susceptibility to cataracts induced by acetaminophen. Science (1978) 200:539–541.
  • LUBEK BM, AVARIA M, BASU PK, WELLS PG: Pharmacological studies on the in vivo cataractogenicity of acetaminophen in mice and rabbits. Found. Appl. Toxicol (1988) 10:596–606.
  • RAUCY JL, LASKER JM, LIEBER CS, BLACK M: Acetaminophen activation by human liver cytochromes P4502 El and P450 1A2. Arch. Biochem. Biophys. (1989) 271:270–283.
  • PATTEN CJ, THOMAS PE, GUY RL et al.: Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem. Res. Toxicol (1993) 6:511–518.
  • THUMMEL KE, LEE CA, KUNZE KL, NELSON SD, SLATTERY JT: Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP 3A4. Biochem. Pharmacol (1993) 45:1563–1569.
  • BESSEMS JGM, VERMEULEN NPE: Paracetamol (acetaminophen)-induced toxicity: Molecular and biochemical mechanisms, analogues and approaches. Grit. Rev Toxicol (2001) 31:55–138.
  • ZHAO C, SHICHI H: Histological study on the possible mechanism of acetaminophen cataractogenesis in mouse eye. Exp. Mol Pathol (1995) 63:118–128.
  • QIAN W, SHICHI H: Cataract formation by a semiquinone metabolite of acetaminophen in mice. Exp. Eye Res. (2000) 71:567–574.
  • ZHAO C, XIONG Y, SHICHI H: Acetaminophen cytotoxicity in mouse eye: mitochondria in anterior tissues are the primary target. I. Ocular Pharmacol Therapeut. (1997) 13:269–274.
  • MATHUR P, PESHENKO IV, SHICHI H: Cellular events preceding acetaminophen cataractogenesis studied by confocal fluorescence microscopy. Ocular Pharmacol Therapeut. (2003) 19:483–492.
  • QIAN W, SHICHI H: Napthoquinone-induced cataract in mice: Possible involvement of Ca2+ release and calpain activation. Ocular Pharmacol Therapeut. (2001) 17:383–392.
  • MARTYNKINA LP, QIAN W, SHICHI H: Naphthoquinone-induced cataract in mice: mitochondrial change and prevention by superoxide dismutase. J. Ocular PharmacolTherapeut. (2002) 18:231–239.
  • WALLACE KB, STARKOV AA: Mitochondrial targets of drug toxicity. Ann. Rev Pharmacol Toxicol (2000) 40:353–388.
  • SPECTOR A: Oxidative stress-induced cataract: mechanism of action. FASEB (1995) 9:1173–1182.
  • REES JR, PIRIE A: Possible reactions of 1, 2-naphthoquinone in the eye. Biochem. (1967) 102:853–863.
  • SATO S, SUGIYAMA K, LEE YS, KADOR PK: Prevention of naphthalene-1, 2-dihydrodiol-induced lens protein modifications by structurally diverse aldose reductase inhibitors. Exp. Eye Res. (1999) 68:601–608.
  • CHRISTEN WG, GLYNN RJ, AJANI UA et al.: Smoking cessation and risk of age-related cataract in man. JAMA (2000) 284:713–716.
  • BLACK RL, OGLASBY R, VON SALLMAN L, BUNIN J: Posterior subcapsular cataract induced by corticoids in patients with rheumatoid arthritis. JAMA (1960) 174:166–171.
  • CUMMING RG, MITCHEL P, LEEDER SR: Use of inhaled corticosterods and the risk of cataracts. N Engl. J. Med. (1997) 337:8–14.
  • DERBY L, MAIER WC: Risk of cataract among users of intranasal corticosteroids. J. Allergy Clin. Immunol (2000) 105:912–916.
  • MANABE S, BUCALA R, CERAMI A: Nonenzymatic addition of glucocorticoids to lens proteins in steroid-induced cataracts. Clin. Invest. (1984) 74:1803–1810.
  • BUCALA R, GALLATI M, MANABE S, COTLIER E, CERAMI A: Glucocorticoid-lens protein adducts in experimentally induced steroid cataracts. Exp. Eye Res. (1985) 40:853–863.
  • NISHIGORI H, LEE JW, YAMAUCHI Y,MARUYAMA K, IWATSURU M: Analysis of glucose levels during glucocorticoid-induced cataract formation in chick embryo. Invest. Ophthalmol Vis. Sci. (1987) 28:168–174.
  • NISHIGORI H: Steroid (glucocorticoid)-induced cataract. Nippon Hakunaisho Gakkai-shi. (1991) 11:5–13.
  • HAMMOND CJ, DUNCAN D, SNIEDER H et al.: The heritability of age-related cortical cataract: The twin eye study. Invest. Ophthalmol Vis. Sci. (2001) 42:601–605.
  • LITT M, KRAMER P, LAM ORTICELLA DM, MURPHY W, 13(6) LOVRIEN FW, WELEBER RG: Autosomal dominant congenital cataract associated with a missense mutation in the human a-crystallin gene CRYAA. Human Ma Genet. (1998) 7:471–474.
  • GILL D, KLOSE R, MUNIER FL et al: Genetic heterogeneity of the Coppock-like cataract: a mutation in CRYBB2 on chromosome 22q11.2. Invest. Ophthalmol Vis. Sci. (2000) 41:159–165.
  • FU L, LIANG JN: Alteration of protein-protein interactions of congenital cataract crystallin mutants. Invest. Ophthalmol Vis. Sci. (2003) 44:1155–1159.
  • HAIDER NB, IKEDA A, NAGGERT JK, NISHINA PM: Genetic modifiers of vision and hearing. Human Ma Genetics (2002) 11:1195–1206.
  • GONG X, AGOPIAN K, KUMAR NM, GILULA NB: Genetic factors influence cataract formation in a-3 connexin knockout mice. Dev. Genet. (1999) 24:27–32.
  • MAEDA YY, FUNATA N, TAKAHAMA S, SUGATA Y, YONEKAWA H: Two interactive genes responsible for a new inherited cataract (RCT) in the mouse. Mamm. Genome (2001) 12:278–283.
  • IONIDES A, FRANCIS P, BERRY V, MACKAY D, BHATTACHARYA S, SHIELDS A et al.: Clinical and genetic heterogeneity in autosomal dominant congenital cataract. Br. Ophthalmol (1999) 83:802–808.
  • CAMPAGNOLI ME PIMAZZONI R, BOSIO S, ZECCHINA G, DEGOBBI M, BOSSO P et al.: Onset of cataract in early infancy associated with 32Gtransitionin the iron responsive element of L-ferritin. Eur.j Pediatr. (2002) 161:499–502.
  • OKANO Y, ASADA M, FUJIMOTO A et al.: A genetic factor for age-related cataract: Identification and characterization of a novel galactokinase variant, 'Osaka,' in Asians. Am. Hum. Genet. (2001) 68:1036–1042.
  • MARAINI G, HEJTMANCIK JF, SHIELDS A et al.: Galactokinase gene mutations and age-related cataract. Lack of association in an Italian population. Mo/. Vis. (2003) 9:397–400.
  • SEKINE Y, HOMMURA S, HARADA S: Frequency of glutathione-Stransferase 1 gene deletion and possible correlation with cataract formation. Exp. Eye Res. (1995) 60:159–163.
  • TOMAREV SI, ZINOVIEVA RD: Squid major lens polypeptides are homologous to glutathione-..Ctransferase subunit. Nature (1988) 336:86–88.
  • TOMAREV SI, ZINOVIEVA RD, PIATIGORSKY J: Crystallins of octopus lens. J. Bio/. Chem. (1991) 226:24226–24231.
  • KLEIN BE, KLEIN R, LINTON KL: Prevalance of age-related lens opacities in a population. The Beaver Dam Eye Study. Ophthalmology (1992) 99:546–552.
  • MITCHELL P, CUMMING RG, ATTEBO K, PANCHAPAKESAN J: Prevalance of cataract in Australia: the Blue Mountains eye study. Ophthalmology (1997) 104:581–588.
  • DEANE JS, HALL AB, THOMPSON JR, ROSENTHAL AR: Prevalence of lenticular abnormalities in a population-based study: Oxford clinical cataract grading in the Melton Eye study. Ophthalmic Epidemiol (1997) 4:195–206.
  • HILLER R, SPERDUTO RD, EDERER F:Epidemiologic associations with nuclear, cortical, and posterior subcapsular cataracts. Am. J. Epidemiol (1986) 124:916–925.
  • WEST SK, MUNOZ B, SCHEIN OD, DUNCAN DD, RUBIN GS: Racial differences in lens opacities: the Salisbury Eye Evaluation (SEE) project. Am. Epidemiol (1998) 148:1033–1039.
  • HAMMOND CJ, DUNCAN D, SNIEDER H et al.: The heritability of age-related cortical cataract: The twin eye study. Invest. Ophthalmol Vis. Sci. (2001) 42:601–605.
  • BOSIA F, GRATTAGLIANO I, VENDEMIALE G, MICELLI-FERRARI T, ALTOMARE E: Protein oxidation and lens opacity in humans. Invest. Ophthalmol Vis. Sci. (2000) 41:2461–2465.
  • BORCHMAN D, YAPPERT MC: Age-related lipid oxidation in human lenses. Invest. Ophthalmol Vis. Sci. (1998) 39:1053–1058.
  • ROSE R, RICHER S, BODE A: Ocular oxidants and antioxidant protection. Proc. Soc. Exp. Biol. Med. (1998) 217:397–407.
  • PIRIE A: Glutathione peroxidase in lens and a source of hydrogen peroxide in aqueous humor. Biochem.f. (1965) 96:244–253.
  • GIBLIN F, McCREADY JP, KODAMA T,REDDY VN: A direct correlation between the levels of ascorbic acid and H202 in aqueous humor. Exp. Eye Res. (1984) 38:87–93.
  • HALLI WELL B, CLEMENT MV, LONG LH: Hydrogen peroxide in the human body. FEBS Lett. (2000) 486:10–13.
  • McGAHAN MC, FLEISHER LN: A micromethod for the determination of iron and total iron-binding capacity in intraocular fluids and plasma using electrothermal atomic absorption spectroscopy. Anal. Biochem. (1986) 156:397–402.
  • TAKIKAWA 0, LITTLEJOHN TK, TRUSCOTT RJW: Indoleamine 2, 3-dioxygenase in the human lens, the first enzyme in the synthesis of UV filters. Exp. Eye Res. (2001) 72:271–277.
  • ITO S: Reexamination of the structure ofeumelanin. Biochim. Biophys. Acta (1986) 883:155–161.
  • LARSSON BS: Interaction between chemicals and melanin. Pigment Cell Res. (1993) 6:127–133.
  • CUMMING RG, MITCHELL P: Alcohol, smoking, and cataract: The Blue Mountains Eye Study. Arch. Ophthalmol (1997) 115:1296–1303.
  • BENEDEK GB: Cataract as a protein condensation disease: The Procter Lecture. Invest. Ophthalmol Vis. ScL (1997) 38:1911–1921.
  • SASO L, SILVESTRINI B: Antidenaturant drugs for cataract and other condensation diseases. Med. Hypotheses (2001) 56:114–120.
  • COTLIER E, SHARIVIA YR: Aspirin and senile cataracts in rheumatoid arthritis. Lancet (1981) 1:338–339.
  • COTLIER E, SHARMA YR, NIVEN T, BRESCIAM: Distribution of salicylate in lens and intraocular fluids and its effect on cataract formation. Am. Med. (1983) 74:83-90. los. CHRISTEN WG, AJANI UA, SCHAUMBERG DA, GLYNN RJ, MANSON JE, HENNEKENS CH: Aspirin use and risk of cataract in posttrial follow-up of physicians' health study I. Arch. Ophthalmol (2001) 119:405–412.
  • HASAN A, SMITH JB, QIN W, SMITH DL: The reaction of bovine lens aA-crystallin with aspirin. Exp. Eye Res. (1993) 57:29–35.
  • BENEDEK GB, PANDE J, THURSTON GM, CLARK JI: Theoretical and experimental basis for the inhibition of cataract. Frogs. Retinal Eye Res. (1999) 18:391–402.
  • KUZNIARZ M, MITCHELL P, CUMMING RG, FLOOD VM: Use of vitamin supplements and cataract: The Blue Mountain Eye Study. Am. I Ophthalinol (2001) 132:19–26.
  • ARED Report No. 9: A randomized placebo-controlled clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss. Arch. Ophthalinol (2001) 119:1439–1452.
  • VAN DER POLS JC: A possible role for vitamin C in age-related cataract. Proc. Nutr. Soc. (1999) 58:295–301.
  • CHENG R, LIN B, LEE KW, ORTWERTH BJ: Similarity of the yellow chromophores isolated from human cataracts with those from ascorbic acid-modified calf lens proteins: evidence for ascorbic acid glycation during cataract formation. Biochlin. Biophys. Acta (2001) 1537:14–26.
  • KLEIN BE, KLEIN R, RITTER LL: Is there evidence of an estrogen effect on age-related lens opacities? Arch. Ophthalinol (1994) 112:85–91.
  • CUMMING R, MITCHELL P: Hormone replacement therapy, reproductive factors, and cataract: the Blue Mountain eye study. Ain. J. Epidentiol (1997) 145:242–249.
  • BIGBY R, CARDENAS H, CAPERELL-GRANT A, GRUBBS CJ: Protective effects of estrogen in a rat model of age-related cataracts. Proc. Natl. Acad. Sci. USA (1999) 96:9328–9332.
  • KIUCHI K, YOSHIZAWA K, MORIGUCHI K, TSUBURA A: Rapid induction of cataract by a single intraperitoneal administration of N-methyl-N-nitrosourea in 15-day-old-Sprague-Dawley (Jcl:SD) rats. Exp. Toxic. Pathol. (2002) 54:181–186.
  • YABE-NISHIMURA C: Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharinacol Rev (1998) 50:21–33.
  • LOU MF, XU GT, ZIGLER S, YORK B: Inhibition of naphthalene cataract in rats by aldose reductase inhibitors. Carr: Eye Res. (1996) 15:423–432.
  • HIGHTOWER KR: Cytotoxic effects of internal calcium on lens physiology: a review. Carr: Eye Res. (1985) 4:453–459.
  • ANDERSSON M, SJOSTRAND J, ANDERSSON AK, ANDERSEN B, KARLSSON JO: Calpains in lens epithelium from patient with cataract. Exp. Eye Res. (1996) 59:359–364.
  • MATSUSHIMA H, DAVID LL, HIRAOKA T, CLARK JI: Loss of cytoskeletal proteins and lens cell opacification in the selenite cataract model. Exp. Eye Res. (1997) 64:387–395.
  • KILLIC F, TREVITHICK JR: Modeling cortical cataractogenesis. XXIX. Calpain proteolysis of lens fodrin in cataract. Biochein. Ma Biol. Intl. (1998) 45:963–978.
  • SCHEY KL, FOWLER JG, SHEARER TR, DAVID L: Modifications to rat lens major intrinsic protein in selenite-induced cataract. Invest. Ophthalinol Vis. Sci. (1999) 40:657–667.
  • TAMADA Y, FUKIAGE C, MIZUTANI K et al.: Calpain inhibitor, SJA 6017, reduces the rate of formation of selenite cataract in rats. Carr. Eye Res. (2001) 22:280–285.
  • TAKEUCHI N, ITO H, NAMIKI K, KAMEI A: Effect of calpain on hereditary cataractous rat, ICR/f. Biol. Pharin. Bull. (2001) 24:1246–1251.
  • MATHUR P, GUPTA S, WEGENER AR et al.: Comparison of various calpain inhibitors in reduction of light scattering in precipitation and nuclear cataract in vitro. Carr. Eye Res. (2000) 21:926–933.
  • YOSHIDA H, MURACHI T, TSUKAHARA I: Distribution of calpain I, calpain II, and calpastatin in bovine lens. Invest. Ophthalinol Vis. Sci. (1985) 26:953–956.
  • AGE-RELATED EYE DISEASE STUDY RESEARCH GROUP: A randomized, placebo-controlled clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss. Arch. Ophthalinol (2001) 119:1439–1452.
  • CHAKARAPANI B, YEDAVALLY S, LEVERENZ V, GIBLIN FJ, REDDY VN: Simultaneous measurement of reduced and oxidized glutathione in human aqueous humor and cataracts by electrochemical detection. Ophthalmic Res. (1995) 27\(Suppl. 1):69–77.
  • KASUYA M, ITOI M, KOBAYASHI S, SUNAGA S, SUZUKI KT: Changes in glutathione and taurine concentrations in lenses of rat eyes induced by galactose-cataract formation or ageing. Exp. Eye Res. (1992) 54:49–53.
  • HIRAOKA T, CLARK JI, LI XY, THURSTON GM: Effect of selected anti-cataract agents on opacification in the selenite cataract model. Exp. Eye Res. (1996) 62:11–19.
  • HEIM KE, TAGLIAFERRO AR, BOBILYA DJ: Flavonoid antioxidants: chemistry, metabolism and structure-activity relationship. Nutrit. Biochein. (2002) 13:572–584.
  • ORHAN H, MAROL S, HEPSEN I, SAHIN G: Effects of some probable antioxidants on selenite-induced cataract formation and oxidative stress-related parameters in rats. Toxicology (1999) 139:219–232.
  • REDDAN J, GIBLIN F, SEVILLA M et al: Propylgallate is a superoxide dismutase mimic and protects cultured lens epithelial cells from H202 insult. Exp. Eye Res. (2003) 76:49–59.
  • SOHAL RS, MOCKETT RJ, ORR WC: Mechanisms of aging: an appraisal of the oxidative stress hypothesis. Free Rad. Biol. Med. (2002) 33:575–586.
  • WEI YH, LEE HC: Oxidative stress, mitochondrial DNA mutation, and impairment of antioxidant enzymes in aging. Exp. Biol. Med. (2002) 227:671–682.
  • MANDAVILLI B, SANTOS J, VANHUTEN B: Mitorhondrial DNA repair and aging. Mutation Res. (2002) 509:127–151.
  • BOVERIS A, CADENAS E: Mitorhondrial production of hydrogen peroxide regulation by nitric oxide and the role of ubisemiquinone. IUBMB Life (2000) 50:245–250.
  • SOHAL RS, WEINDRUCH R: Oxidative stress, caloric restriction, and aging. Science (1996) 273:59–63.
  • WALLACE DC: Mitorhondrial DNA sequence variation in human evolution and disease. Proc. Natl. Acad. Sci. USA 0994) 91:8739–8746.
  • RICHTER C, PARK JVV, AMES BN: Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc. Nati Acad. Sci. USA (1988) 85:6465–6467.
  • BEHNDIG A, SVENSSON B, MARKLUND SL, KARLSSON K: Superoxide dismutase isozymes in the human eye. Invest. Ophthahnol. Vis. Sci. (1998) 39:471–475.
  • REDDY VN: Glutathione and its function in the lens - an overview. Exp. Eye Res. (1990) 50:771–778.
  • ALLEN JA, COOMBS MM: Covalent binding of polycyclic aromatic compounds to mitochondrial and nuclear DNA. Nature (1980) 287:244–245.
  • ADACHI K, FUJIURA Y, MARUMI F et al.: A deletion of mitochondrial DNA in murine doxorubicin-induced cardiotoxicity. Biochem. Biophys. Res. Commun. (1993) 195:945–951.
  • LIANG FQ, GODLEY BF: Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age- related macular degeneration. Exp. Eye Res.(2003) 76:397–403.
  • LANE MA, INGRAM DK, ROTH GS: The serious search for an anti-aging pill. Sci. Am. (2002) 287:36-41. Websites

Websites

  • http://www.ncbi.nlm.nih.gov/Omim Online Mendelian Inheritance in Man, OM/M

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.